Autologous Protein Solution Therapy
For patients suffering from osteoarthritis or whose doctors have recommended joint replacement surgery, Beyond Biologics™ offers Autologous Protein Solution (APS) therapy, a non-surgical solution for joint pain.
APS therapy is a protein injection harvested from the patient’s blood. The treatment is designed to treat pain and slow the progression of cartilage degradation and joint destruction.
If you are experiencing joint pain and want to slow joint degradation and avoid surgery, contact Beyond Biologics™ today to find out if APS therapy is right for you.
Treatments
Relieve pain, prevent injury, and be well with APS
Knee
Osteoarthritis
Hip
Osteoarthritis
Shoulder
Osteoarthritis
Elbow & hand
Osteoarthritis
Foot & ankle
Osteoarthritis
The breakdown
What is the science behind APS?
APS injections are a treatment for osteoarthritis pain. Osteoarthritis is characterized by an increased number of catabolic, pro-inflammatory cytokines in the joint. When they are not balanced by anti-inflammatory cytokines, the catabolic cytokines contribute to cartilage breakdown. As cartilage degrades, the joint becomes increasingly arthritic and symptoms (generally pain, stiffness, and swelling) increase.
APS injections work by targeting the cytokine imbalance with a concentration of anti-inflammatory cytokines and anabolic growth factors. This concentration is injected directly at the site of the joint injury and spurs regenerative healing.
Process
01 Harvest
APS therapy begins with the provider withdrawing a small amount of the patient’s blood. This sample of blood contains the healing properties that will be re-injected back into the osteoarthritic joint.
02 Concentrate
Beyond Biologics™ will then centrifuge the blood sample, concentrating white blood cells, platelets, and plasma proteins into a small volume of anti-inflammatory solution.
03 Administer
Two to three cc of the anti-inflammatory solution will then be directly injected into the osteoarthritic joint using ultrasound guidance, reducing joint pain and improving joint function.
APS injections
Key benefits of APS treatment
DECREASED RISK VS. SURGERY
Since APS therapy is a conservative approach to joint osteoarthritis and requires no incisions, bleeding, infections, and post-procedure complications are extremely rare– especially compared to surgery. The procedure is safe for all age groups, genders, and levels of activity. It is also safe for patients with interfering medical conditions.
PAIN RELIEF & IMPROVED FUNCTION
APS therapy releases growth factors that enhance tissue regeneration and healing. This leads to better outcomes and a faster healing time for patients, with none of the downtime associated with surgery. As an effective pain relief treatment and promoter of faster healing, APS often improves the function of the osteoarthritic joint beyond what the patient thought possible. It also can eliminate the need for surgery and prolonged recovery.
OUTPATIENT PROCEDURE
All Beyond Biologics™ APS injections are performed in a comfortable office setting. Patients are fully conscious during the procedure, which eliminates significant risks as well as the costs associated with anesthesia. Since APS injections are a non-surgical treatment option, procedures can take as little as 30 minutes.
LESS COSTLY THAN SURGERY
Compared to joint replacement surgery, an APS injection procedure at Beyond Biologics™ offers patients significant savings. For one thing, patients are spared the hidden costs of facility fees and anesthesia. Additionally, since APS is a non-surgical treatment with very little risk of complication, there is no need for patients to rack up fees by staying overnight in a hospital.
NATURAL HEALING
APS injections promote tissue repair by harnessing the body’s natural healing process. Nothing synthetic is added to the body–merely the patient’s own blood cells.
APS injection for knee osteoarthritis
A recent study titled Clinical Outcomes of Knee Osteoarthritis Treated With an Autologous Protein Solution Injection: A 1-Year Pilot Double-Blinded Randomized Controlled Trial provides evidence to support the safety and clinical improvement at 1-year follow-up of a single intra-articular injection of APS in patients affected by knee osteoarthritis. Treatment with APS or a saline injection provided significant pain relief over the course of the study with differences becoming apparent at between 6 and 12 months after treatment.
